AUPO104496A0 - Angiogenic inhibitory compounds - Google Patents

Angiogenic inhibitory compounds

Info

Publication number
AUPO104496A0
AUPO104496A0 AUPO1044A AUPO104496A AUPO104496A0 AU PO104496 A0 AUPO104496 A0 AU PO104496A0 AU PO1044 A AUPO1044 A AU PO1044A AU PO104496 A AUPO104496 A AU PO104496A AU PO104496 A0 AUPO104496 A0 AU PO104496A0
Authority
AU
Australia
Prior art keywords
inhibitory compounds
angiogenic inhibitory
dendrimer
anionic
cationic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO1044A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomolecular Research Institute Ltd
Original Assignee
Biomolecular Research Institute Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomolecular Research Institute Ltd filed Critical Biomolecular Research Institute Ltd
Priority to AUPO1044A priority Critical patent/AUPO104496A0/en
Publication of AUPO104496A0 publication Critical patent/AUPO104496A0/en
Priority to EP97929038A priority patent/EP0927217B1/en
Priority to AT97929038T priority patent/ATE325154T1/de
Priority to CNB971964521A priority patent/CN1161128C/zh
Priority to CA002262862A priority patent/CA2262862C/en
Priority to PCT/AU1997/000447 priority patent/WO1998003573A1/en
Priority to DE69735810T priority patent/DE69735810T2/de
Priority to US09/230,188 priority patent/US6426067B1/en
Priority to JP10506372A priority patent/JP2000516211A/ja
Priority to PT97929038T priority patent/PT927217E/pt
Priority to ES97929038T priority patent/ES2260796T3/es
Priority to BR9710375A priority patent/BR9710375A/pt
Priority to KR1019997000264A priority patent/KR100564714B1/ko
Priority to NZ333488A priority patent/NZ333488A/xx
Priority to DK97929038T priority patent/DK0927217T3/da
Priority to AU33302/97A priority patent/AU715761C/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/36—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino acids, polyamines and polycarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002—Dendritic macromolecules
    • C08G83/003—Dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10—Alpha-amino-carboxylic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/16—Dendrimers and dendritic polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Liquid Crystal Substances (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polyamides (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AUPO1044A 1996-07-17 1996-07-17 Angiogenic inhibitory compounds Abandoned AUPO104496A0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
AUPO1044A AUPO104496A0 (en) 1996-07-17 1996-07-17 Angiogenic inhibitory compounds
AU33302/97A AU715761C (en) 1996-07-17 1997-07-17 Angiogenic inhibitory compounds
DE69735810T DE69735810T2 (de) 1996-07-17 1997-07-17 Antiangiogenische verbindungen
JP10506372A JP2000516211A (ja) 1996-07-17 1997-07-17 血管形成抑制化合物
CNB971964521A CN1161128C (zh) 1996-07-17 1997-07-17 抑制血管生成的化合物
CA002262862A CA2262862C (en) 1996-07-17 1997-07-17 Angiogenic inhibitory compounds
PCT/AU1997/000447 WO1998003573A1 (en) 1996-07-17 1997-07-17 Angiogenic inhibitory compounds
EP97929038A EP0927217B1 (en) 1996-07-17 1997-07-17 Angiogenic inhibitory compounds
US09/230,188 US6426067B1 (en) 1996-07-17 1997-07-17 Angiogenic inhibitory compounds
AT97929038T ATE325154T1 (de) 1996-07-17 1997-07-17 Antiangiogenische verbindungen
PT97929038T PT927217E (pt) 1996-07-17 1997-07-17 Compostos inibidores angiogenicos
ES97929038T ES2260796T3 (es) 1996-07-17 1997-07-17 Compuestos inhibidores angiogenicos.
BR9710375A BR9710375A (pt) 1996-07-17 1997-07-17 Processo e composi-Æo farmac-utica ou veterin ria para a inibi-Æo profil tica ou terap-utica da angiog-nese em um ser humano ou animal nÆo humano uso de um pol¡mero ou dendr¡mero tendo uma pluralidade de grupos terminais
KR1019997000264A KR100564714B1 (ko) 1996-07-17 1997-07-17 혈관 형성을 억제하는 화합물
NZ333488A NZ333488A (en) 1996-07-17 1997-07-17 Polymeric angiogenic inhibitory compounds
DK97929038T DK0927217T3 (da) 1996-07-17 1997-07-17 Antiangiogene forbindelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO1044A AUPO104496A0 (en) 1996-07-17 1996-07-17 Angiogenic inhibitory compounds

Publications (1)

Publication Number Publication Date
AUPO104496A0 true AUPO104496A0 (en) 1996-08-08

Family

ID=3795360

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO1044A Abandoned AUPO104496A0 (en) 1996-07-17 1996-07-17 Angiogenic inhibitory compounds

Country Status (15)

Country Link
US (1) US6426067B1 (enExample)
EP (1) EP0927217B1 (enExample)
JP (1) JP2000516211A (enExample)
KR (1) KR100564714B1 (enExample)
CN (1) CN1161128C (enExample)
AT (1) ATE325154T1 (enExample)
AU (1) AUPO104496A0 (enExample)
BR (1) BR9710375A (enExample)
CA (1) CA2262862C (enExample)
DE (1) DE69735810T2 (enExample)
DK (1) DK0927217T3 (enExample)
ES (1) ES2260796T3 (enExample)
NZ (1) NZ333488A (enExample)
PT (1) PT927217E (enExample)
WO (1) WO1998003573A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018637B2 (en) * 1998-02-23 2006-03-28 Aventis Pasteur, Inc Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
FR2781485B1 (fr) 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
AUPP584298A0 (en) * 1998-09-14 1998-10-08 Starpharma Limited Antimicrobial and antiparasitic agents
GB0001481D0 (en) * 2000-01-21 2000-03-15 Theryte Ltd System for delivering a medicament
HUP0301621A3 (en) * 2000-03-27 2009-06-29 Scripps Research Inst Use of integrin inhibitor for inhibiting angiogenesis and tumor growth
KR100413532B1 (ko) * 2001-02-14 2003-12-31 학교법인 포항공과대학교 폴리아민이 말단에 치환된 덴드리머 및 그 제조방법
AUPR412801A0 (en) * 2001-03-30 2001-05-03 Starpharma Limited Agent for the prevention and treatment of sexually transmitted disease s - I
AUPR412901A0 (en) * 2001-03-30 2001-05-03 Starpharma Limited Agents for the prevention and treatment of sexually transmitted disease s - II
US20030135195A1 (en) * 2002-01-16 2003-07-17 Oscar Jimenez Highly lubricious hydrophilic coating utilizing dendrimers
US20030180250A1 (en) * 2002-03-22 2003-09-25 Council Of Scientific And Industrial Research Compositions and complexes containing a macromolecular compound as potential anti-inflammatory agents
KR20060015534A (ko) 2003-04-25 2006-02-17 더 펜 스테이트 리서치 파운데이션 성장 억제, 지질 유래된 생활성 화합물의 전신 전달을 위한방법 및 시스템
EP1756041B1 (en) 2004-06-15 2013-08-07 Polymedix, Inc. Polycationic compounds and uses thereof
FR2876916B1 (fr) * 2004-10-25 2007-01-05 Midi Pyrenees Incubateur Produit implantable de surface fonctionnalisee au moyen de dendrimeres a terminaisons anioniques
KR100667171B1 (ko) 2005-05-10 2007-01-12 서애희 세포내 물질전달용 ｐａｍａｍ 유도체 및 이를 이용한세포내 원하는 물질의 전달방법
GR1005807B (el) * 2005-07-13 2008-02-06 Αρισταρχος Παπαγιανναρος Ρυθμιστικο λιποσωμιακο συστημα ελεγχομενης αποδεσμευσης: νεα φαρμακοτεχνικη μορφη για εγκλωβισμο αντικαρκινικων φαρμακων με βαση την τεχνολογια των λιποσωματων και των δενδριμερων
WO2007045010A1 (en) * 2005-10-21 2007-04-26 Starpharma Pty Limited Inhibitory compounds
DE102005056592A1 (de) * 2005-11-25 2007-05-31 Basf Ag Herstellung und Verwendung von hochfunktionellen, hoch-oder hyperverzweigten Polylysinen
CA2636599C (en) 2006-01-20 2014-07-15 Starpharma Pty Limited Modified macromolecule
US8193248B2 (en) 2006-03-22 2012-06-05 Starpharma Pty Limited Contraceptive composition
DE102006036326A1 (de) * 2006-08-03 2008-02-07 Charité - Universitätsmedizin Berlin Dendritische Polyglycerolsulfate und -sulfonate und deren Verwendung bei entzündlichen Erkrankungen
US20080311177A1 (en) 2007-06-14 2008-12-18 Massachusetts Institute Of Technology Self Assembled Films for Protein and Drug Delivery Applications
US8658148B2 (en) * 2007-06-22 2014-02-25 Genzyme Corporation Chemically modified dendrimers
US10106565B2 (en) 2008-08-01 2018-10-23 Centre National De La Recherche Scientifique Phosphorylated dendrimers as antiinflammatory drugs
WO2010013086A1 (en) * 2008-08-01 2010-02-04 Centre National De La Recherche Scientifique Phosphorylated dendrimers as antiinflammatory drugs
US9198875B2 (en) 2008-08-17 2015-12-01 Massachusetts Institute Of Technology Controlled delivery of bioactive agents from decomposable films
CA2836168C (en) * 2011-05-16 2019-09-24 Starpharma Pty Ltd Method of treatment or prophylaxis of bacterial vaginosis
WO2013163234A1 (en) 2012-04-23 2013-10-31 Massachusetts Institute Of Technology Stable layer-by-layer coated particles
WO2014134029A1 (en) 2013-02-26 2014-09-04 Massachusetts Institute Of Technology Nucleic acid particles, methods and use thereof
WO2014150074A1 (en) 2013-03-15 2014-09-25 Massachusetts Institute Of Technology Compositions and methods for nucleic acid delivery
TWI586369B (zh) * 2015-01-26 2017-06-11 國立交通大學 樹狀化合物、具有功能性基團的樹狀化合物以及抗體
DE102017002810A1 (de) 2017-03-22 2018-09-27 Reinhard Brossmer Sialinsäurederivate mit C-C Dreifachbindung und deren Herstellung
US11419947B2 (en) 2017-10-30 2022-08-23 Massachusetts Institute Of Technology Layer-by-layer nanoparticles for cytokine therapy in cancer treatment
EP3975841A1 (en) 2019-05-30 2022-04-06 Massachusetts Institute of Technology Peptide nucleic acid functionalized hydrogel microneedles for sampling and detection of interstitial fluid nucleic acids

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2182667B1 (enExample) * 1972-05-03 1978-03-03 Rhone Poulenc Ind
US4289872A (en) * 1979-04-06 1981-09-15 Allied Corporation Macromolecular highly branched homogeneous compound based on lysine units
US4410688A (en) 1981-04-29 1983-10-18 Allied Corporation Macromolecular highly branched homogeneous compound
HU187669B (en) * 1982-03-31 1986-02-28 Richter Gedeon Vegyeszet Process for producing new copolymeres and salts
US4568737A (en) 1983-01-07 1986-02-04 The Dow Chemical Company Dense star polymers and dendrimers
US4507466A (en) 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
US4558120A (en) 1983-01-07 1985-12-10 The Dow Chemical Company Dense star polymer
US4587329A (en) 1984-08-17 1986-05-06 The Dow Chemical Company Dense star polymers having two dimensional molecular diameter
NL8900442A (nl) * 1989-02-22 1990-09-17 Stichting Rega V Z W Gesulfateerde vinylpolymeren in geneesmiddelen voor het behandelen van retrovirus-infecties.
JP2909500B2 (ja) * 1989-03-23 1999-06-23 ベルレックス、ラボラトリーズ、レンコーポレイテッド 水溶性抗高脂質血症剤として有用な官能化側鎖を有するポリアミド
FR2669535A1 (fr) * 1990-11-26 1992-05-29 Medgenix Group Sa Utilisation a titre de medicament de macromolecules polysulfonees.
GB2260134A (en) 1991-10-04 1993-04-07 Erba Carlo Spa Derivatives of poly-5-amino-3-carboxy-1-methyl compounds
EP0622078B1 (en) * 1992-01-14 1999-09-01 Hisamitsu Pharmaceutical Co., Inc. Cholesterol level depressant
EP0655923A1 (en) 1992-08-19 1995-06-07 Merrell Pharmaceuticals Inc. Antiangiogenic oligomers
US5460807A (en) * 1992-08-19 1995-10-24 Merrell Dow Pharmaceuticals Inc. Antiproliferative oligomers
IL108951A0 (en) 1994-03-13 1994-06-24 Hadasit Med Res Service Pharmaceutical compositions containing polysulfated polysaccharides
JPH07267879A (ja) 1994-03-30 1995-10-17 Unitika Ltd 血管新生阻害剤
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers

Also Published As

Publication number Publication date
NZ333488A (en) 2000-07-28
JP2000516211A (ja) 2000-12-05
AU3330297A (en) 1998-02-10
CN1161128C (zh) 2004-08-11
PT927217E (pt) 2006-08-31
EP0927217A4 (en) 2003-04-23
DK0927217T3 (da) 2006-08-14
WO1998003573A1 (en) 1998-01-29
ATE325154T1 (de) 2006-06-15
US6426067B1 (en) 2002-07-30
KR20000067876A (ko) 2000-11-25
BR9710375A (pt) 1999-08-17
EP0927217A1 (en) 1999-07-07
DE69735810T2 (de) 2006-12-21
DE69735810D1 (de) 2006-06-08
CA2262862A1 (en) 1998-01-29
KR100564714B1 (ko) 2006-03-28
CA2262862C (en) 2005-10-04
AU715761B2 (en) 2000-02-10
ES2260796T3 (es) 2006-11-01
CN1225654A (zh) 1999-08-11
EP0927217B1 (en) 2006-05-03

Similar Documents

Publication Publication Date Title
AUPO104496A0 (en) Angiogenic inhibitory compounds
EP0765357B8 (en) Antiviral dendrimers
CA2203480A1 (en) Interferon conjugates
AU9551598A (en) Light-emitting dendrimers and devices
MX9605206A (es) 1alfa,26-dihidroxi-d-homo-vitamina d3.
PT825186E (pt) Derivados de 2-aminobenzazepina e sua utilizacao para o tratamento da imunossupressao
NZ333541A (en) Antiviral polyionic linear polymers for treatment of HIV, RSV, influenza, hepatitis and other enveloped viruses
CA2062653A1 (en) Promotion of wound-healing with 15-keto-prostaglandin compounds
MXPA01011606A (es) Terapia anti-inflamatoria para infeccion mediada por inflamacion.
ZA898440B (en) Lactamimides in the treatment of drug-resistant protozoal infections
WO2002011737A3 (en) Anti-inflammatory medicament
EP0656408A3 (en) Compositions for joining organosiloxane elastomers to organic polymers.
BG102667A (en) Diosgenine-containing composition
AU5390900A (en) Potassium channel blocking agents
AU4466397A (en) Prevention of gastrointestinal damage
WO2003057693A1 (en) 5-membered cyclic compounds
AU6686894A (en) Antiviral thiazoles
MX9801792A (es) Inhibidores cicloantihelminticos.
CA2261802A1 (en) Use of xanomeline for treating bipolar disorder
AU6290398A (en) Inclusion complexes in aqueous solution
AU1979397A (en) Peptidomimetics for the treatment of hiv infection
BR9901387A (pt) Composições para a cura de polìmero.
RU1839143C (ru) Гидромеханический поворотный прихват
AU3974997A (en) Thrombin inhibitors
EP0832983A4 (enExample)